APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-Invasive BCI

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Non-Invasive BCI Market Outlook and Growth Opportunities 2026

13 August 2026194 pages

Choose your research edition.

Industry ResearchNon-Invasive BCI Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-Invasive BCI Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Non-Invasive BCI Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-Invasive BCI Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-Invasive BCI Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Non-Invasive BCI market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Non-Invasive BCI is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Non-Invasive BCI is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-Invasive BCI is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Non-Invasive BCI market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Non-Invasive BCI market include NIHON KOHDEN CORPORATION, Integra LifeSciences, Advanced Brain Monitoring, Cadwell Industries, OpenBCI, Cortech Solutions, NeuroSky, Emotiv and G.tec Medical Engineering GmbH, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Non-Invasive BCI market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Non-Invasive BCI and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Non-Invasive BCI sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Non-Invasive BCI market size, projected growth trends, production technologies, key applications, and end-use industries.

Non-Invasive BCI Segment by Company

NIHON KOHDEN CORPORATION

Integra LifeSciences

Advanced Brain Monitoring

Cadwell Industries

OpenBCI

Cortech Solutions

NeuroSky

Emotiv

G.tec Medical Engineering GmbH

Natus Medical Incorporated

Non-Invasive BCI Segment by Type

EEG

FMRI

NIRS

MEG

ECOG

Non-Invasive BCI Segment by Application

Healthcare

Communication and Control

Entertainment and Gaming

Smart Home Control

Others

Non-Invasive BCI Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Non-Invasive BCI status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Non-Invasive BCI market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Non-Invasive BCI significant trends, drivers, influence factors in global and regions.

6. To analyze Non-Invasive BCI competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-Invasive BCI market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-Invasive BCI and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-Invasive BCI.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Non-Invasive BCI market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Non-Invasive BCI industry.

Chapter 3: Detailed analysis of Non-Invasive BCI manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Non-Invasive BCI in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Non-Invasive BCI in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Non-Invasive BCI Industry Trends Table 2. Non-Invasive BCI Industry Drivers Table 3. Non-Invasive BCI Industry Opportunities and Challenges Table 4. Non-Invasive BCI Industry Restraints Table 5. Global Non-Invasive BCI Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Non-Invasive BCI Revenue Share by Company (2021-2026) Table 7. Global Non-Invasive BCI Sales Volume by Company (k units) & (2021-2026) Table 8. Global Non-Invasive BCI Sales Volume Share by Company (2021-2026) Table 9. Global Non-Invasive BCI Average Price (USD/unit) of Company (2021-2026) Table 10. Global Non-Invasive BCI Company Ranking, (2024-2026) & (USD Million) Table 11. Global Non-Invasive BCI Key Company Manufacturing Base & Headquarters Table 12. Global Non-Invasive BCI Company, Product Type & Application Table 13. Global Non-Invasive BCI Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Non-Invasive BCI by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of EEG Table 18. Significant Companies of FMRI Table 19. Significant Companies of NIRS Table 20. Significant Companies of MEG Table 21. Significant Companies of ECOG Table 22. Global Non-Invasive BCI Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 23. Global Non-Invasive BCI Sales Volume by Type (2021-2026) & (k units) Table 24. Global Non-Invasive BCI Sales Volume by Type (2027-2032) & (k units) Table 25. Global Non-Invasive BCI Sales Volume Share by Type (2021-2026) Table 26. Global Non-Invasive BCI Sales Volume Share by Type (2027-2032) Table 27. Global Non-Invasive BCI Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Non-Invasive BCI Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Non-Invasive BCI Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Non-Invasive BCI Sales Value Share by Type (2021-2026) Table 31. Global Non-Invasive BCI Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Healthcare Table 33. Significant Companies of Communication and Control Table 34. Significant Companies of Entertainment and Gaming Table 35. Significant Companies of Smart Home Control Table 36. Significant Companies of Others Table 37. Global Non-Invasive BCI Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Non-Invasive BCI Sales Volume by Application (2021-2026) & (k units) Table 39. Global Non-Invasive BCI Sales Volume by Application (2027-2032) & (k units) Table 40. Global Non-Invasive BCI Sales Volume Share by Application (2021-2026) Table 41. Global Non-Invasive BCI Sales Volume Share by Application (2027-2032) Table 42. Global Non-Invasive BCI Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global Non-Invasive BCI Sales Value by Application (2021-2026) & (US$ Million) Table 44. Global Non-Invasive BCI Sales Value by Application (2027-2032) & (US$ Million) Table 45. Global Non-Invasive BCI Sales Value Share by Application (2021-2026) Table 46. Global Non-Invasive BCI Sales Value Share by Application (2027-2032) Table 47. Global Non-Invasive BCI Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 48. Global Non-Invasive BCI Sales by Region (2021-2026) & (k units) Table 49. Global Non-Invasive BCI Sales Market Share by Region (2021-2026) Table 50. Global Non-Invasive BCI Sales by Region (2027-2032) & (k units) Table 51. Global Non-Invasive BCI Sales Market Share by Region (2027-2032) Table 52. Global Non-Invasive BCI Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Non-Invasive BCI Sales Value by Region (2021-2026) & (US$ Million) Table 54. Global Non-Invasive BCI Sales Value Share by Region (2021-2026) Table 55. Global Non-Invasive BCI Sales Value by Region (2027-2032) & (US$ Million) Table 56. Global Non-Invasive BCI Sales Value Share by Region (2027-2032) Table 57. Global Non-Invasive BCI Market Average Price (USD/unit) by Region (2021-2026) Table 58. Global Non-Invasive BCI Market Average Price (USD/unit) by Region (2027-2032) Table 59. Global Non-Invasive BCI Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 60. Global Non-Invasive BCI Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Non-Invasive BCI Sales by Country (2021-2026) & (k units) Table 62. Global Non-Invasive BCI Sales Market Share by Country (2021-2026) Table 63. Global Non-Invasive BCI Sales by Country (2027-2032) & (k units) Table 64. Global Non-Invasive BCI Sales Market Share by Country (2027-2032) Table 65. Global Non-Invasive BCI Sales Value by Country (2021-2026) & (US$ Million) Table 66. Global Non-Invasive BCI Sales Value Market Share by Country (2021-2026) Table 67. Global Non-Invasive BCI Sales Value by Country (2027-2032) & (US$ Million) Table 68. Global Non-Invasive BCI Sales Value Market Share by Country (2027-2032) Table 69. NIHON KOHDEN CORPORATION Company Information Table 70. NIHON KOHDEN CORPORATION Business Overview Table 71. NIHON KOHDEN CORPORATION Non-Invasive BCI Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 72. NIHON KOHDEN CORPORATION Non-Invasive BCI Product Portfolio Table 73. NIHON KOHDEN CORPORATION Recent Development Table 74. Integra LifeSciences Company Information Table 75. Integra LifeSciences Business Overview Table 76. Integra LifeSciences Non-Invasive BCI Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 77. Integra LifeSciences Non-Invasive BCI Product Portfolio Table 78. Integra LifeSciences Recent Development Table 79. Advanced Brain Monitoring Company Information Table 80. Advanced Brain Monitoring Business Overview Table 81. Advanced Brain Monitoring Non-Invasive BCI Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 82. Advanced Brain Monitoring Non-Invasive BCI Product Portfolio Table 83. Advanced Brain Monitoring Recent Development Table 84. Cadwell Industries Company Information Table 85. Cadwell Industries Business Overview Table 86. Cadwell Industries Non-Invasive BCI Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 87. Cadwell Industries Non-Invasive BCI Product Portfolio Table 88. Cadwell Industries Recent Development Table 89. OpenBCI Company Information Table 90. OpenBCI Business Overview Table 91. OpenBCI Non-Invasive BCI Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. OpenBCI Non-Invasive BCI Product Portfolio Table 93. OpenBCI Recent Development Table 94. Cortech Solutions Company Information Table 95. Cortech Solutions Business Overview Table 96. Cortech Solutions Non-Invasive BCI Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Cortech Solutions Non-Invasive BCI Product Portfolio Table 98. Cortech Solutions Recent Development Table 99. NeuroSky Company Information Table 100. NeuroSky Business Overview Table 101. NeuroSky Non-Invasive BCI Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. NeuroSky Non-Invasive BCI Product Portfolio Table 103. NeuroSky Recent Development Table 104. Emotiv Company Information Table 105. Emotiv Business Overview Table 106. Emotiv Non-Invasive BCI Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Emotiv Non-Invasive BCI Product Portfolio Table 108. Emotiv Recent Development Table 109. G.tec Medical Engineering GmbH Company Information Table 110. G.tec Medical Engineering GmbH Business Overview Table 111. G.tec Medical Engineering GmbH Non-Invasive BCI Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. G.tec Medical Engineering GmbH Non-Invasive BCI Product Portfolio Table 113. G.tec Medical Engineering GmbH Recent Development Table 114. Natus Medical Incorporated Company Information Table 115. Natus Medical Incorporated Business Overview Table 116. Natus Medical Incorporated Non-Invasive BCI Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Natus Medical Incorporated Non-Invasive BCI Product Portfolio Table 118. Natus Medical Incorporated Recent Development Table 119. Key Raw Materials Table 120. Raw Materials Key Suppliers Table 121. Non-Invasive BCI Distributors List Table 122. Non-Invasive BCI Customers List Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Non-Invasive BCI Product Image Figure 2. Global Non-Invasive BCI Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-Invasive BCI Sales Value (2021-2032) & (US$ Million) Figure 4. Global Non-Invasive BCI Sales (2021-2032) & (k units) Figure 5. Global Non-Invasive BCI Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Non-Invasive BCI Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. EEG Image Figure 10. FMRI Image Figure 11. NIRS Image Figure 12. MEG Image Figure 13. ECOG Image Figure 14. Global Non-Invasive BCI Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Non-Invasive BCI Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Non-Invasive BCI Sales Volume Share by Type (2021-2032) Figure 17. Global Non-Invasive BCI Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Non-Invasive BCI Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Non-Invasive BCI Sales Value Share by Type (2021-2032) Figure 20. Healthcare Image Figure 21. Communication and Control Image Figure 22. Entertainment and Gaming Image Figure 23. Smart Home Control Image Figure 24. Others Image Figure 25. Global Non-Invasive BCI Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global Non-Invasive BCI Sales Volume Share 2021 VS 2025 VS 2032 Figure 27. Global Non-Invasive BCI Sales Volume Share by Application (2021-2032) Figure 28. Global Non-Invasive BCI Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Non-Invasive BCI Sales Value Share 2021 VS 2025 VS 2032 Figure 30. Global Non-Invasive BCI Sales Value Share by Application (2021-2032) Figure 31. Global Non-Invasive BCI Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 32. Global Non-Invasive BCI Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 33. Global Non-Invasive BCI Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 34. Global Non-Invasive BCI Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 35. North America Non-Invasive BCI Sales Value (2021-2032) & (US$ Million) Figure 36. North America Non-Invasive BCI Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Europe Non-Invasive BCI Sales Value (2021-2032) & (US$ Million) Figure 38. Europe Non-Invasive BCI Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Asia-Pacific Non-Invasive BCI Sales Value (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Non-Invasive BCI Sales Value Share by Country (%), 2025 VS 2032 Figure 41. South America Non-Invasive BCI Sales Value (2021-2032) & (US$ Million) Figure 42. South America Non-Invasive BCI Sales Value Share by Country (%), 2025 VS 2032 Figure 43. Middle East & Africa Non-Invasive BCI Sales Value (2021-2032) & (US$ Million) Figure 44. Middle East & Africa Non-Invasive BCI Sales Value Share by Country (%), 2025 VS 2032 Figure 45. USA Non-Invasive BCI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. USA Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. USA Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Canada Non-Invasive BCI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Canada Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Canada Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Mexico Non-Invasive BCI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Mexico Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Mexico Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Germany Non-Invasive BCI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Germany Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Germany Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. France Non-Invasive BCI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. France Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. France Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. U.K. Non-Invasive BCI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. U.K. Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. U.K. Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Italy Non-Invasive BCI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Italy Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Italy Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Spain Non-Invasive BCI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Spain Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Spain Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Russia Non-Invasive BCI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Russia Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Russia Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Netherlands Non-Invasive BCI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Netherlands Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Netherlands Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Nordic Countries Non-Invasive BCI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Nordic Countries Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Nordic Countries Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. China Non-Invasive BCI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. China Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. China Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Japan Non-Invasive BCI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Japan Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Japan Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. South Korea Non-Invasive BCI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. South Korea Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. South Korea Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. India Non-Invasive BCI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. India Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. India Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Australia Non-Invasive BCI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Australia Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Australia Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Southeast Asia Non-Invasive BCI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Southeast Asia Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Southeast Asia Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Brazil Non-Invasive BCI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Brazil Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Brazil Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Argentina Non-Invasive BCI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Argentina Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Argentina Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Chile Non-Invasive BCI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Chile Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Chile Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Colombia Non-Invasive BCI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Colombia Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Colombia Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Peru Non-Invasive BCI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Peru Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Peru Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Non-Invasive BCI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Saudi Arabia Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Israel Non-Invasive BCI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Israel Arabia Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Israel Arabia Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. UAE Non-Invasive BCI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. UAE Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. UAE Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Turkey Non-Invasive BCI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Turkey Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Turkey Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Iran Non-Invasive BCI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Iran Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Iran Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Egypt Non-Invasive BCI Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 127. Egypt Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032 & (%) Figure 128. Egypt Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032 & (%) Figure 129. Non-Invasive BCI Value Chain Figure 130. Manufacturing Cost Structure Figure 131. Non-Invasive BCI Sales Mode & Process Figure 132. Direct Comparison with Distribution Share Figure 133. Distributors Profiles Figure 134. Years Considered Figure 135. Research Process Figure 136. Key Executives Interviewed

Scope & coverage.

Types
  • EEG
  • FMRI
  • NIRS
  • MEG
  • ECOG
Applications
  • Healthcare
  • Communication and Control
  • Entertainment and Gaming
  • Smart Home Control
  • Others
Companies covered
  • NIHON KOHDEN CORPORATION
  • Integra LifeSciences
  • Advanced Brain Monitoring
  • Cadwell Industries
  • OpenBCI
  • Cortech Solutions
  • NeuroSky
  • Emotiv
  • G.tec Medical Engineering GmbH
  • Natus Medical Incorporated

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Non-Invasive BCI Sales Value (2021-2032)
  4. 1.2.2 Global Non-Invasive BCI Sales Volume (2021-2032)
  5. 1.2.3 Global Non-Invasive BCI Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Non-Invasive BCI Market Dynamics
  1. 2.1 Non-Invasive BCI Industry Trends
  2. 2.2 Non-Invasive BCI Industry Drivers
  3. 2.3 Non-Invasive BCI Industry Opportunities and Challenges
  4. 2.4 Non-Invasive BCI Industry Restraints
3 Non-Invasive BCI Market by Company
  1. 3.1 Global Non-Invasive BCI Company Revenue Ranking in 2025
  2. 3.2 Global Non-Invasive BCI Revenue by Company (2021-2026)
  3. 3.3 Global Non-Invasive BCI Sales Volume by Company (2021-2026)
  4. 3.4 Global Non-Invasive BCI Average Price by Company (2021-2026)
  5. 3.5 Global Non-Invasive BCI Company Ranking (2024-2026)
  6. 3.6 Global Non-Invasive BCI Company Manufacturing Base and Headquarters
  7. 3.7 Global Non-Invasive BCI Company Product Type and Application
  8. 3.8 Global Non-Invasive BCI Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Non-Invasive BCI Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Non-Invasive BCI Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Non-Invasive BCI Market by Type
  1. 4.1 Non-Invasive BCI Type Introduction
  2. 4.1.1 EEG
  3. 4.1.2 FMRI
  4. 4.1.3 NIRS
  5. 4.1.4 MEG
  6. 4.1.5 ECOG
  7. 4.2 Global Non-Invasive BCI Sales Volume by Type
  8. 4.2.1 Global Non-Invasive BCI Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Non-Invasive BCI Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Non-Invasive BCI Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Non-Invasive BCI Sales Value by Type
  12. 4.3.1 Global Non-Invasive BCI Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Non-Invasive BCI Sales Value by Type (2021-2032)
  14. 4.3.3 Global Non-Invasive BCI Sales Value Share by Type (2021-2032)
5 Non-Invasive BCI Market by Application
  1. 5.1 Non-Invasive BCI Application Introduction
  2. 5.1.1 Healthcare
  3. 5.1.2 Communication and Control
  4. 5.1.3 Entertainment and Gaming
  5. 5.1.4 Smart Home Control
  6. 5.1.5 Others
  7. 5.2 Global Non-Invasive BCI Sales Volume by Application
  8. 5.2.1 Global Non-Invasive BCI Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Non-Invasive BCI Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Non-Invasive BCI Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Non-Invasive BCI Sales Value by Application
  12. 5.3.1 Global Non-Invasive BCI Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Non-Invasive BCI Sales Value by Application (2021-2032)
  14. 5.3.3 Global Non-Invasive BCI Sales Value Share by Application (2021-2032)
6 Non-Invasive BCI Regional Sales and Value Analysis
  1. 6.1 Global Non-Invasive BCI Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Non-Invasive BCI Sales by Region (2021-2032)
  3. 6.2.1 Global Non-Invasive BCI Sales by Region: 2021-2026
  4. 6.2.2 Global Non-Invasive BCI Sales by Region (2027-2032)
  5. 6.3 Global Non-Invasive BCI Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Non-Invasive BCI Sales Value by Region (2021-2032)
  7. 6.4.1 Global Non-Invasive BCI Sales Value by Region: 2021-2026
  8. 6.4.2 Global Non-Invasive BCI Sales Value by Region (2027-2032)
  9. 6.5 Global Non-Invasive BCI Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Non-Invasive BCI Sales Value (2021-2032)
  12. 6.6.2 North America Non-Invasive BCI Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Non-Invasive BCI Sales Value (2021-2032)
  15. 6.7.2 Europe Non-Invasive BCI Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Non-Invasive BCI Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Non-Invasive BCI Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Non-Invasive BCI Sales Value (2021-2032)
  21. 6.9.2 South America Non-Invasive BCI Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Non-Invasive BCI Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Non-Invasive BCI Sales Value Share by Country, 2025 VS 2032
7 Non-Invasive BCI Country-level Sales and Value Analysis
  1. 7.1 Global Non-Invasive BCI Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Non-Invasive BCI Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Non-Invasive BCI Sales by Country (2021-2032)
  4. 7.3.1 Global Non-Invasive BCI Sales by Country (2021-2026)
  5. 7.3.2 Global Non-Invasive BCI Sales by Country (2027-2032)
  6. 7.4 Global Non-Invasive BCI Sales Value by Country (2021-2032)
  7. 7.4.1 Global Non-Invasive BCI Sales Value by Country (2021-2026)
  8. 7.4.2 Global Non-Invasive BCI Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Non-Invasive BCI Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Non-Invasive BCI Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Non-Invasive BCI Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Non-Invasive BCI Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Non-Invasive BCI Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Non-Invasive BCI Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Non-Invasive BCI Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Non-Invasive BCI Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Non-Invasive BCI Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Non-Invasive BCI Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Non-Invasive BCI Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Non-Invasive BCI Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Non-Invasive BCI Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Non-Invasive BCI Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Non-Invasive BCI Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Non-Invasive BCI Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Non-Invasive BCI Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Non-Invasive BCI Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Non-Invasive BCI Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Non-Invasive BCI Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Non-Invasive BCI Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Non-Invasive BCI Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Non-Invasive BCI Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Non-Invasive BCI Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Non-Invasive BCI Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Non-Invasive BCI Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Non-Invasive BCI Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Non-Invasive BCI Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Non-Invasive BCI Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Non-Invasive BCI Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 NIHON KOHDEN CORPORATION
  2. 8.1.1 NIHON KOHDEN CORPORATION Company Information
  3. 8.1.2 NIHON KOHDEN CORPORATION Business Overview
  4. 8.1.3 NIHON KOHDEN CORPORATION Non-Invasive BCI Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 NIHON KOHDEN CORPORATION Non-Invasive BCI Product Portfolio
  6. 8.1.5 NIHON KOHDEN CORPORATION Recent Developments
  7. 8.2 Integra LifeSciences
  8. 8.2.1 Integra LifeSciences Company Information
  9. 8.2.2 Integra LifeSciences Business Overview
  10. 8.2.3 Integra LifeSciences Non-Invasive BCI Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Integra LifeSciences Non-Invasive BCI Product Portfolio
  12. 8.2.5 Integra LifeSciences Recent Developments
  13. 8.3 Advanced Brain Monitoring
  14. 8.3.1 Advanced Brain Monitoring Company Information
  15. 8.3.2 Advanced Brain Monitoring Business Overview
  16. 8.3.3 Advanced Brain Monitoring Non-Invasive BCI Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Advanced Brain Monitoring Non-Invasive BCI Product Portfolio
  18. 8.3.5 Advanced Brain Monitoring Recent Developments
  19. 8.4 Cadwell Industries
  20. 8.4.1 Cadwell Industries Company Information
  21. 8.4.2 Cadwell Industries Business Overview
  22. 8.4.3 Cadwell Industries Non-Invasive BCI Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Cadwell Industries Non-Invasive BCI Product Portfolio
  24. 8.4.5 Cadwell Industries Recent Developments
  25. 8.5 OpenBCI
  26. 8.5.1 OpenBCI Company Information
  27. 8.5.2 OpenBCI Business Overview
  28. 8.5.3 OpenBCI Non-Invasive BCI Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 OpenBCI Non-Invasive BCI Product Portfolio
  30. 8.5.5 OpenBCI Recent Developments
  31. 8.6 Cortech Solutions
  32. 8.6.1 Cortech Solutions Company Information
  33. 8.6.2 Cortech Solutions Business Overview
  34. 8.6.3 Cortech Solutions Non-Invasive BCI Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Cortech Solutions Non-Invasive BCI Product Portfolio
  36. 8.6.5 Cortech Solutions Recent Developments
  37. 8.7 NeuroSky
  38. 8.7.1 NeuroSky Company Information
  39. 8.7.2 NeuroSky Business Overview
  40. 8.7.3 NeuroSky Non-Invasive BCI Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 NeuroSky Non-Invasive BCI Product Portfolio
  42. 8.7.5 NeuroSky Recent Developments
  43. 8.8 Emotiv
  44. 8.8.1 Emotiv Company Information
  45. 8.8.2 Emotiv Business Overview
  46. 8.8.3 Emotiv Non-Invasive BCI Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Emotiv Non-Invasive BCI Product Portfolio
  48. 8.8.5 Emotiv Recent Developments
  49. 8.9 G.tec Medical Engineering GmbH
  50. 8.9.1 G.tec Medical Engineering GmbH Company Information
  51. 8.9.2 G.tec Medical Engineering GmbH Business Overview
  52. 8.9.3 G.tec Medical Engineering GmbH Non-Invasive BCI Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 G.tec Medical Engineering GmbH Non-Invasive BCI Product Portfolio
  54. 8.9.5 G.tec Medical Engineering GmbH Recent Developments
  55. 8.10 Natus Medical Incorporated
  56. 8.10.1 Natus Medical Incorporated Company Information
  57. 8.10.2 Natus Medical Incorporated Business Overview
  58. 8.10.3 Natus Medical Incorporated Non-Invasive BCI Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Natus Medical Incorporated Non-Invasive BCI Product Portfolio
  60. 8.10.5 Natus Medical Incorporated Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Non-Invasive BCI Value Chain Analysis
  2. 9.1.1 Non-Invasive BCI Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Non-Invasive BCI Sales Mode & Process
  6. 9.2 Non-Invasive BCI Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Non-Invasive BCI Distributors
  9. 9.2.3 Non-Invasive BCI Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst